NCT03043560View on ClinicalTrials.gov

Study to Treat Major Depressive Disorder With a New Medication

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions
Depressive DisorderAnhedonia
Interventions
DRUG

Ezogabine

daily for 5 weeks

DRUG

Placebos

placebo pill daily for 5 weeks

Trial Locations (2)

10029

Icahn School of Medicine at Mount Sinai, New York

77030

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Baylor College of Medicine

OTHER

lead

James Murrough

OTHER

NCT03043560 - Study to Treat Major Depressive Disorder With a New Medication | Biotech Hunter | Biotech Hunter